Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Express Scripts
US Army
Cantor Fitzgerald
Dow
Chubb
Novartis
Julphar
Queensland Health
Baxter

Generated: August 17, 2017

DrugPatentWatch Database Preview

Cetyl alcohol; colfosceril palmitate; tyloxapol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cetyl alcohol; colfosceril palmitate; tyloxapol and what is the scope of cetyl alcohol; colfosceril palmitate; tyloxapol patent protection?

Cetyl alcohol; colfosceril palmitate; tyloxapol
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are eighty-nine drug master file entries for cetyl alcohol; colfosceril palmitate; tyloxapol.

Summary for Generic Name: cetyl alcohol; colfosceril palmitate; tyloxapol

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list89
Clinical Trials: see list1,353
Drug Prices:see low prices
DailyMed Link:cetyl alcohol; colfosceril palmitate; tyloxapol at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
EXOSURF NEONATAL
cetyl alcohol; colfosceril palmitate; tyloxapol
FOR SUSPENSION;INTRATRACHEAL020044-001Aug 2, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cetyl alcohol; colfosceril palmitate; tyloxapol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
EXOSURF NEONATAL
cetyl alcohol; colfosceril palmitate; tyloxapol
FOR SUSPENSION;INTRATRACHEAL020044-001Aug 2, 1990► Subscribe► Subscribe
Glaxosmithkline
EXOSURF NEONATAL
cetyl alcohol; colfosceril palmitate; tyloxapol
FOR SUSPENSION;INTRATRACHEAL020044-001Aug 2, 1990► Subscribe► Subscribe
Glaxosmithkline
EXOSURF NEONATAL
cetyl alcohol; colfosceril palmitate; tyloxapol
FOR SUSPENSION;INTRATRACHEAL020044-001Aug 2, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Daiichi Sankyo
Accenture
Baxter
Cantor Fitzgerald
US Army
Julphar
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot